Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Launched by MEMORIAL SLOAN KETTERING CANCER CENTER · Jan 7, 2008

Keywords

ClinConnect Summary

**Clinical Trial Summary: Molecular Characterization of Neuroblastic Tumor**

This clinical trial aims to better understand neuroblastic tumors, a type of cancer that can affect children. Researchers are studying the genetic and biochemical characteristics of these tumors to learn how they grow and develop. This information could help determine how aggressive the tumor is and what treatments might work best for each patient. Participants in the study will have various tests, including blood samples and tests of their tumor’s makeup, to help gather important information about their condition.

If you or your child has been diagnosed with a neuroblastic tumor according to specific guidelines, you might be eligible to participate in this study. There are no strict age or gender requirements, and even those suspected of having a neuroblastic tumor may qualify. Participants can expect to provide blood and other samples, which will be analyzed to look for cancer cells or other important markers. This research is ongoing, and your involvement could contribute to better treatments for neuroblastoma in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Neuroblastic tumors diagnosed in accordance with the International Neuroblastoma Staging System
• • OR
• • Clinically suspected neuroblastic tumors.
• PK DRAW INCLUSION CRITERIA (FOR PK DRAWS ONLY):
• • PK Draw Inclusion Criteria
• • Patients who receive naxitamab as part of their standard of care
• Exclusion Criteria:
• • None